Analyst Price Target is $19.67
▲ +8.78% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is $19.67, with a high forecast of $20.00 and a low forecast of $18.00. The average price target represents a 8.78% upside from the last price of $18.08.
Current Consensus is
Moderate Buy
The current consensus among 7 polled investment analysts is to moderate buy stock in Sabra Healthcare REIT. This rating has held steady since November 2023, when it changed from a Hold consensus rating.